Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items concerning the last two weeks of February 2024.
See previous edition Psychedelics Headlines: Trauma-Informed Care, Valentine’s Day & MDMA, Academics On Drugs
Research
- Validation of the Psychedelic Predictor Scale (original read.)
- Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin [Research funded by Brain and Cognition Discovery Foundation (BCDF), Usona, and Braxia Scientific BRAXF.]
- Development of a digital intervention for psychedelic preparation (DIPP) (read.)
- Critical Psychedelic Studies: Correcting the Hype, a symposium organized by Harvard's Petrie Flom Center (access essays.)
- Psilocybin and the Development of Serotonin Toxicity (case report.)
Tune In, Get Smart
- This Test Predicts How Ready You Are for a Psychedelic Experience, by Psychedelic Vantage (read.)
- Beyond the Psychedelic Competitive Moat: Chasing the Patent Dragon, on Harvard's Petrie Flom Center (read.)
- There's no such thing as ‘evidence-based' drug policy, by Criminal Justice Prof. Alex Stevens for Transforming Society (read.)
- The Most Common Extended Difficulties Following Psychedelic Use, by Sam Woolfe (read.)
- Good Drugs, Bad Drugs, by Dr. Peter Grinspoon (read.)
- Macrodosing vs. Microdosing: Let's Break It All Down, by Sam Woolfe for HealingMaps (read.)
- The Risks Of Underground Psychedelic Training Programmes, by Jules Evans (read.)
- Opinion: How Ayahuasca Could Change You, on Psychedelics Today (read.)
- Pablo Amaringo Drank Ayahuasca at 10 Years Old, Then Ushered In a Global Art Tradition, by the DoubleBlind team (read.)
- Psychedelic Breathwork: Altering Consciousness Without Drugs, by Chemical Collective (read.)
- Behold the Ascendant Psychedelic Vape, by Lucid News (read.)
- BBCRadio4's new programme on synthetic opioids, featuring David Aaronovitch, Alex Stevens, Caroline Copeland, Rick Treble and Sam Quinones (listen.)
- Hamilton Morris and Jordan Rubin discuss the Analogue Act, "one of the most confusing laws in the history of American drug policy" (listen.)
- Are new psychedelic guides trained for adverse events? Jules Evans and Sam Woolfe's review on 31 psychedelic training centers (read.)
- aNUma was contracted by UC- Berkeley's Center for the Science of Psychedelics certificate program to explore psychedelic facilitation training with an innovative digital platform (details.)
- Imperial College London launched a new survey to understand the psychedelic therapy underground practices and how they differ from clinical trials (participate.)
- March 5 Transform Drugs Policy Foundation talks with UK's Psychedelic Society on its recent proposals on legally regulating psychedelics for non-medical use (register.)
- March 9 SXSW 2024 with several panels on psychedelics, including "FDA Approved Love? Exploring MDMA’s Psychedelic Journey" (browse schedule.)
- March 10 MAPS Canada event: "Cafe Scientifique on Psychedelics and Health Equity: An Interactive Public Dialogue with Leading Researchers in Canada" (register.)
- March 13 The Global Commission on Drug Policy (GCDP) event: Bridging the gap – Reassessing drug policy through a human rights lens (register.)
- March 19 Harvard event: New Ideas for Substance Use Condition Treatment: Could Psychedelics Help? (register.)
- March 20 The Drug Education Forum launch: Join the new national community of drug education professionals from across the UK's Spring 2024 launch event (register.)
- The Loop UK is offering a series of online drug testing and harm reduction training courses (see list.)
Panorama Pulse
- Optimi Health OPTHF announced the closing of the first tranche of its non-brokered private placement.
- Filament Health FLHLF completed the first export of botanical psilocybin to Israel.
- Silo Wellness SILFF announced extension of the Kaya Holdings-NUGL LOI, plus an annual filings delay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.